385P Efficacy and safety of pyrotinib in untreated, advanced non-small cell lung cancer with HER2 mutations: A parallel, multi-center, multi-cohort patient-centric study (CTONG1702 and 1705)

S-Y.M. Liu,H-Y. Tu, X-W. Wei,H-H. Yan, X. Dong, J. Cui, Z. Zhou,C. Xu,M. Zheng, Y. Li,Z. Wang,Y. Du,Y. Chen, R. Ma,B. Wang, S. Cang,J-J. Yang,H. Chen, Q. Zhou,Y-L. Wu

Annals of Oncology(2022)

引用 0|浏览0
暂无评分
关键词
her2 mutations,lung cancer,pyrotinib,non-small,multi-center,multi-cohort,patient-centric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要